Journey Medical Corp (DERM)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Claude Maraoui
Employees:
90
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ 85258
480-434-6670

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the. treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an. oral doxycycline drug for. adjunctive therapy for severe acne, Ximino, and Exelderm cream for topical use.

Data derived from most recent annual or quarterly report
Market Cap 46.764 Million Shares Outstanding17.32 Million Avg 30-day Volume 185.683 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.46
Price to Revenue0.4657 Debt to Equity1988.4 EBITDA-32.073 Million
Price to Book Value5725.6075 Operating Margin-59.7085 Enterprise Value21.59 Million
Current Ratio0.699 EPS Growth0.377 Quick Ratio0.366
1 Yr BETA 0.3862 52-week High/Low 3.19 / 1.02 Profit Margin-63.8082
Operating Cash Flow Growth-647.6351 Free Cash Flow to Firm (FCFF) TTM -7.218 Million Free Cash Flow to Equity (FCFE) TTM53.4 Million
Altman Z-Score-2.7162
Earnings Report2023-11-09

Are you looking for this stock instead?

View SEC Filings from DERM instead.

View recent insider trading info

Journey Medical Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding DERM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DERM

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-09-08 by MARAOUI CLAUDE
  • 4: filed on 2023-07-25 by SMITH JUSTIN ADAM
  • 4: filed on 2023-07-25 by MARAOUI CLAUDE
  • 4: filed on 2023-07-25 by BENESCH JOSEPH
  • 4: filed on 2023-05-18 by MARAOUI CLAUDE
  • 4: filed on 2023-02-23 by BENESCH JOSEPH
  • 3: filed on 2023-01-31 by BENESCH JOSEPH
  • 4: filed on 2022-10-06 by DE PAOLANTONIO ERNEST ROBERT
  • 4: filed on 2022-07-25 by ROSENWALD LINDSAY A MD
  • 4: filed on 2022-07-25 by SMITH JUSTIN ADAM

    • Events (8k)

  • 8-K: filed on 2023-09-26:
    Item 8.01: Other Events
  • 8-K: filed on 2023-09-19:
    Item 8.01: Other Events
  • 8-K: filed on 2023-09-06:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-18:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-26:
    Item 8.01: Other Events
  • 8-K: filed on 2023-06-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-22:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.02: Results of Operations and Financial Condition
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    156 Thousand total shares from 3 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PALEY JEFFREY

    • Director
    		 57,472 2023-09-21 2

    ROSENWALD LINDSAY A MD

    • Director
    		 290,715 2023-09-06 1

    MARAOUI CLAUDE PRESIDENT & CEO

    • Officer
    • Director
    		 2,153,430 2023-09-06 3

    BENESCH JOSEPH SEE REMARKS

    • Officer
    		 63,160 2023-07-24 3

    HERSKOWITZ NEIL

    • Director
    		 71,717 2023-07-21 1

    TOLEDANO MIRANDA JAYNE

    • Director
    		 71,717 2023-07-21 1

    SMITH JUSTIN ADAM

    • Director
    		 71,717 2023-07-21 1

    DE PAOLANTONIO ERNEST ROBERT SEE REMARKS

    • Officer
    		 259,907 2022-10-04 2

    BALD EAGLE ACQUISITION CORP

    ELI LILLY & CO

    • 10% Owner
    		 100 2020-02-20 0

    CRAVES FRED B

    • Director
    		 0 2020-02-20 0

    WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

    • Officer
    • Director
    		 0 2020-02-20 0

    BAUER EUGENE A CHIEF MEDICAL OFFICER

    • Officer
    • Director
    		 19,932 2020-02-20 0

    GUGGENHIME ANDREW CFO

    • Officer
    		 0 2020-02-20 0

    RINGO WILLIAM R

    • Director
    		 0 2020-02-20 0

    MCDADE MARK

    • Director
    		 0 2020-02-20 0

    COHEN DAVID E

    • Director
    		 0 2020-02-20 0

    FUST MATTHEW K

    • Director
    		 0 2020-02-20 0

    NUNN JASON RALEIGH

    • Director
    		 0 2020-02-20 0

    GILBERT HALLEY E

    • Director
    		 0 2020-02-20 0

    GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

    • Officer
    		 0 2020-02-20 0

    PENA LUIS C. CHIEF DEVELOPMENT OFFICER

    • Officer
    		 0 2020-02-20 0

    SEBELIUS KATHLEEN

    • Director
    		 0 2020-02-20 0

    LYONS-WILLIAMS LORI CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2020-02-20 0

    HORAN CHRISTOPHER CHIEF TECHNICAL OPS OFFICER

    • Officer
    		 0 2020-02-20 0

    AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

    • Officer
    		 0 2020-02-20 0

    BARRIS PETER J

    • 10% Owner
    		 3,502,922 2014-10-08 0

    BARRETT M JAMES

    • 10% Owner
    		 3,502,922 2014-10-08 0

    MOTT DAVID M

    • 10% Owner
    		 3,502,922 2014-10-08 0

    KERINS PATRICK J

    • 10% Owner
    		 3,502,922 2014-10-08 0

    SANDELL SCOTT D

    • 10% Owner
    		 3,502,922 2014-10-08 0

    KOLLURI KRISHNA KITTU

    • 10% Owner
    		 3,502,922 2014-10-08 0

    BASKETT FOREST

    • 10% Owner
    		 3,502,922 2014-10-08 0

    BAY CITY CAPITAL LLC

    BAY CITY CAPITAL MANAGEMENT V LLC

    BAY CITY CAPITAL FUND V, L.P.

    BAY CITY CAPITAL FUND V CO-INVESTMENT FUND, L.P.

    • Director
    • 10% Owner
    		 3,506,647 2014-10-08 0

    DRANT RYAN D

    • 10% Owner
    		 3,502,922 2014-10-08 0

    HUTTON WENDE S

    • Director
    		 2,500,149 2014-10-08 0

    WELLER HARRY R

    • 10% Owner
    		 3,502,922 2014-10-08 0

    CANAAN VIII LP

    CANAAN PARTNERS VIII LLC

    • Director
    • 10% Owner
    		 2,500,149 2014-10-08 0

    NEW ENTERPRISE ASSOCIATES 13 LP

    NEA 13 GP, LTD

    NEA PARTNERS 13, LIMITED PARTNERSHIP

    • 10% Owner
    		 3,502,922 2014-10-08 0

    VISWANATHAN RAVI

    • 10% Owner
    		 3,502,922 2014-10-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    PALEY JEFFREY - Director

    		2023-09-25 16:01:37 -0400 2023-09-21 P 30,000 $2.97 a 57,472 direct

    ROSENWALD LINDSAY A MD - Director

    		2023-09-08 13:25:10 -0400 2023-09-06 P 100,000 $2.23 a 114,245 direct -3.0508 -9.8305 0.0 1 -15.2542 5

    MARAOUI CLAUDE - Director - Officer PRESIDENT & CEO

    		2023-09-08 13:26:00 -0400 2023-09-06 P 26,044 $2.52 a 2,153,430 direct -3.0508 -9.8305 0.0 1 -15.2542 5

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    JOURNEY MEDICAL CORP DERM 2023-09-27 22:15:05 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 21:45:03 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 21:15:04 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 20:45:04 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 20:15:05 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 19:45:03 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 19:15:04 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 18:45:04 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 18:15:04 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 17:45:03 UTC 0.0 0.0 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 17:15:03 UTC 0.0 0.0 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 16:45:04 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 16:15:05 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 15:45:04 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 15:15:03 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 14:45:03 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 14:15:03 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 13:45:03 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 13:15:05 UTC -7.8836 13.2036 300000
    JOURNEY MEDICAL CORP DERM 2023-09-27 12:45:05 UTC -7.8836 13.2036 65000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments